Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
-
Published:2022-10-03
Issue:1
Volume:11
Page:
-
ISSN:2047-2994
-
Container-title:Antimicrobial Resistance & Infection Control
-
language:en
-
Short-container-title:Antimicrob Resist Infect Control
Author:
Dakorah Mavis Puopelle,Agyare Elizabeth,Acolatse Joseph Elikem Efui,Akafity George,Stelling John,Chalker Victoria J.,Spiller Owen B.,Aidoo Nana Benyin,Kumi-Ansah Frederick,Azumah Daniel,Laryea Stephen,Incoom Robert,Ngyedu Eric Kofi
Abstract
Abstract
Background
Antimicrobial resistance (AMR) is a major public health challenge with its impact felt disproportionately in Western Sub-Saharan Africa. Routine microbiology investigations serve as a rich source of AMR monitoring and surveillance data. Geographical variations in susceptibility patterns necessitate regional and institutional tracking of resistance patterns to aid in tailored Antimicrobial Stewardship (AMS) interventions to improve antibiotic use in such settings. This study focused on developing a cumulative antibiogram of bacterial isolates from clinical samples at the Cape Coast Teaching Hospital (CCTH). This was ultimately to improve AMS by guiding empiric therapy.
Methods
A hospital-based longitudinal study involving standard microbiological procedures was conducted from 1st January to 31st December 2020. Isolates from routine diagnostic aerobic cultures were identified by colony morphology, Gram staining, and conventional biochemical tests. Isolates were subjected to antibiotic susceptibility testing using Kirby-Bauer disc diffusion. Inhibitory zone diameters were interpreted per the Clinical and Laboratory Standards Institute guidelines and were entered and analysed on the WHONET software using the “first isolate only” principle.
Results
Overall, low to moderate susceptibility was observed in most pathogen-antibiotic combinations analysed in the study. Amikacin showed the highest susceptibility (86%, n = 537/626) against all Gram-negatives with ampicillin exhibiting the lowest (6%, n = 27/480). Among the Gram-positives, the highest susceptibilities were exhibited by gentamicin (78%, n = 124/159), with clindamycin having the lowest susceptibility (27%, n = 41/154). Among the Gram-negatives, 66% (n = 426/648) of the isolates were identified phenotypically as potential extended-spectrum beta-lactamase producers. Multiple multidrug-resistant isolates were also identified among both Gram-positive and Gram-negative isolates. Low to moderate susceptibility was found against first- and second-line antibiotics recommended in the National standard treatment guidelines (NSTG). Laboratory quality management deficiencies and a turnaround time of 3.4 days were the major AMS barriers identified.
Conclusions
Low to moderate susceptibilities coupled with high rates of phenotypic resistance warrant tailoring NSTGs to fit local contexts within CCTH even after considering the biases in these results. The cumulative antibiogram proved a key AMS programme component after its communication to clinicians and subsequent monitoring of its influence on prescribing indicators. This should be adopted to enhance such programmes across the country.
Funder
The World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) and the WHO regional offices for Africa, the Americas, Europe and South-East Asia
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health
Reference43 articles.
1. Murray CJ, Shunji Ikuta K, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations the review on antimicrobial resistance. (2016). https://amr-review.org/sites/default/files/160518_Finalpaper_withcover.pdf. Accessed 27 Jul 2021.
3. World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. Geneva: World Health Organization; 2019. p. 88.
4. Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021;11(6):1–43.
5. Ministry of Health, Ministry of Food and Agriculture, Ministry of Environment, Science Technology and Innovation, Ministry of Fisheries and Aquaculture Development. Republic of Ghana Policy on Antimicrobial Use and Resistance 1st Edition, 2017. Accra; 2017. p. 48. https://www.moh.gov.gh/wp-content/uploads/2018/04/AMR-POLICY-A5_09.03.2018-Signed.pdf
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献